Stocks
Charles River Laboratories International () EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | 563.1 | 768.5 | 820.2 | 986.1 | 1 032 | 1 018 | ||
| Changes by years, y/y, % | +37% | +36% | +7% | +20% | +5% | +20.3% | |||
Charles River Laboratories International. EBITDA US GAAP, bln rub
Charles River Laboratories International. EBITDA US GAAP, changes, %
Charles River Laboratories International. EBITDA US GAAP, sum by quarters, bln rub
Charles River Laboratories International () EBITDA US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| EBITDA, bln rub | ? | 242.5 | 241.4 | 225.5 | 322.8 | 228.3 | 1 018 | |
| Changes by years, y/y, % | +24% | +30% | +8% | +2% | -6% | |||
| Changes by quarters, q/q, % | -23% | 0% | -7% | +43% | -29% | |||
